Log In
BCIQ
Print this Print this
 

SPN-812

  Manage Alerts
Collapse Summary General Information
Company Supernus Pharmaceuticals Inc.
DescriptionSelective norepinephrine reuptake inhibitor
Molecular Target
Mechanism of ActionNorepinephrine reuptake inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat ADHD
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today